LOGICMARK INC (LGMK)

US67091J5039 - Common Stock

1.58  +0.02 (+1.28%)

After market: 1.52 -0.06 (-3.8%)

Fundamental Rating

2

Taking everything into account, LGMK scores 2 out of 10 in our fundamental rating. LGMK was compared to 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of LGMK is average, but there are quite some concerns on its profitability. LGMK does not seem to be growing, but still is valued expensively.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year LGMK has reported negative net income.
LGMK had a negative operating cash flow in the past year.
LGMK had negative earnings in each of the past 5 years.
LGMK had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -96.85%, LGMK is doing worse than 81.82% of the companies in the same industry.
With a Return On Equity value of -109.71%, LGMK is not doing good in the industry: 65.78% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -96.85%
ROE -109.71%
ROIC N/A
ROA(3y)-55.89%
ROA(5y)-45.83%
ROE(3y)-62.38%
ROE(5y)-72.24%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of LGMK (66.72%) is better than 71.66% of its industry peers.
LGMK's Gross Margin has been stable in the last couple of years.
LGMK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.19%
GM growth 5Y-1.39%

More info and screens

6

2. Health

2.1 Basic Checks

LGMK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LGMK has been increased compared to 1 year ago.
LGMK has more shares outstanding than it did 5 years ago.
LGMK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -8.74, we must say that LGMK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -8.74, LGMK is doing worse than 77.54% of the companies in the same industry.
There is no outstanding debt for LGMK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.74
ROIC/WACCN/A
WACC9.21%

2.3 Liquidity

LGMK has a Current Ratio of 3.73. This indicates that LGMK is financially healthy and has no problem in meeting its short term obligations.
LGMK has a better Current ratio (3.73) than 67.38% of its industry peers.
A Quick Ratio of 3.29 indicates that LGMK has no problem at all paying its short term obligations.
LGMK has a better Quick ratio (3.29) than 68.45% of its industry peers.
Industry RankSector Rank
Current Ratio 3.73
Quick Ratio 3.29

More info and screens

0

3. Growth

3.1 Past

The earnings per share for LGMK have decreased strongly by -455.81% in the last year.
LGMK shows a small growth in Revenue. In the last year, the Revenue has grown by 4.44%.
LGMK shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.32% yearly.
EPS 1Y (TTM)-455.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-354.55%
Revenue 1Y (TTM)4.44%
Revenue growth 3Y-4.62%
Revenue growth 5Y-10.32%
Sales Q2Q%14.15%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y98.68%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LGMK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LGMK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LGMK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LOGICMARK INC

NASDAQ:LGMK (12/20/2024, 8:22:15 PM)

After market: 1.52 -0.06 (-3.8%)

1.58

+0.02 (+1.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners12.14%
Inst Owner Change336.43%
Ins Owners8%
Ins Owner Change74.7%
Market Cap2.86M
Analysts43.33
Price Target4.08 (158.23%)
Short Float %N/A
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP-1.93%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.22%
Min EPS beat(2)12.04%
Max EPS beat(2)54.4%
EPS beat(4)4
Avg EPS beat(4)18.43%
Min EPS beat(4)1.96%
Max EPS beat(4)54.4%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.64%
Min Revenue beat(2)-3.51%
Max Revenue beat(2)8.78%
Revenue beat(4)2
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)8.78%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)471.43%
PT rev (3m)471.43%
EPS NQ rev (1m)-12.38%
EPS NQ rev (3m)-12.38%
EPS NY rev (1m)-0.93%
EPS NY rev (3m)64.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)2.78%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 0.2
P/tB 0.54
EV/EBITDA N/A
EPS(TTM)-31.58
EYN/A
EPS(NY)-2.21
Fwd EYN/A
FCF(TTM)-2.22
FCFYN/A
OCF(TTM)-2.2
OCFYN/A
SpS5.57
BVpS7.82
TBVpS2.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -96.85%
ROE -109.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.72%
FCFM N/A
ROA(3y)-55.89%
ROA(5y)-45.83%
ROE(3y)-62.38%
ROE(5y)-72.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.19%
GM growth 5Y-1.39%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.79%
Cap/Sales 0.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.73
Quick Ratio 3.29
Altman-Z -8.74
F-Score4
WACC9.21%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-455.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-354.55%
EPS Next Y98.68%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.44%
Revenue growth 3Y-4.62%
Revenue growth 5Y-10.32%
Sales Q2Q%14.15%
Revenue Next Year1.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.1%
OCF growth 3YN/A
OCF growth 5YN/A